Metabolic Syndrome and Obesity‐related cancer Risk and Survival: An Umbrella Review of Systematic Reviews With Meta‐analysis of Observational Studies
Obesity Reviews · 2026
DOI: 10.1111/obr.70073 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Obesity Reviews, 2026. Verfasst von Maci Winn und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Metabolic Syndrome, Obesity, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Introduction
Metabolic syndrome (MetS) may be associated with obesity‐related cancer (ORC) owing to shared risk factors like physical inactivity, insulin resistance, gut microbiome dysfunction, and inflammation. We conducted an umbrella review of systematic reviews with meta‐analysis to synthesize the evidence on the association between MetS and ORC risk and survival.
Methods
Searches in five databases (Medline, Embase, CINAHL, Cochrane Library, and Scopus) retrieved 2524 systematic reviews with meta‐analyses (SRMAs), which underwent title and abstract screening (2524), full‐text review (41), and data extraction for included SRMAs (21). Summary effects and 95% confidence intervals were re‐estimated using random‐effects models. Methodological quality, certainty of evidence, and publication bias were assessed using the AMSTAR 2, modified Ioannidis criteria, and Egger's test, respectively.
Results
A total of 25 associations between MetS and ORC risk and five between MetS and survival were evaluated. Overall, 10 associations evaluating MetS and ORC risk were highly suggestive (four) or suggestive (six), while the rest were classified as weak (seven) or nonsignificant (eight). One association was suggestive for MetS and ORC survival, while the rest were classified as weak (three) or nonsignificant (one). The Egger's and excess significance tests were significant for 8(32%) associations between MetS and ORC risk and 3(60%) associations between MetS and ORC survival.
Conclusion
This umbrella review suggests metabolic syndrome increases the risk of several obesity‐related cancers and worsens colorectal cancer survival. Despite study variability, consistent associations across diverse populations highlight the urgency of prevention and management strategies targeting metabolic dysfunction to reduce cancer burden. Summary In this umbrella review, highly suggestive and suggestive evidence supports associations between MetS and the risk and survival of several obesity‐related cancers. However, a better understanding of the relationship between metabolic syndrome and obesity‐related cancers is still needed to provide appropriate clinical care, design optimal interventions, and prevent subsequent increases in the risks of cancer, morbidity, and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA.
- Huntsman Cancer Institute, Salt Lake City, Utah, USA.
- Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.
- Department of Epidemiology, Geisel School of Medicine at Dartmouth College, Lebanon, New Hampshire, USA.
- University of California San Francisco, Bakar Computational Health Sciences Institute, San Francisco, California, USA.
- Department of Radiation Oncology, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Maci Winn, Prasoona Karra, Win Khaing, Mary M McFarland, Yizhe Xu, Michelle Litchman
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Winn, M., Karra, P., Benson, R., Pauleck, S., Chaiyakunapruk, N., Khaing, W., Veettil, S. K., McFarland, M. M., Casucci, T., Xu, Y., Hu-Lieskovan, S., Litchman, M., Playdon, M., & Hardikar, S. (2026). Metabolic Syndrome and Obesity‐related cancer Risk and Survival: An Umbrella Review of Systematic Reviews With Meta‐analysis of Observational Studies. Obesity Reviews. https://doi.org/10.1111/obr.70073
Vancouver
Winn M, Karra P, Benson R, Pauleck S, Chaiyakunapruk N, Khaing W, et al. Metabolic Syndrome and Obesity‐related cancer Risk and Survival: An Umbrella Review of Systematic Reviews With Meta‐analysis of Observational Studies. Obesity Reviews. 2026. doi:10.1111/obr.70073
BibTeX
@article{Winn2026,
author = {Winn, Maci and Karra, Prasoona and Benson, Ryzen and Pauleck, Svenja and Chaiyakunapruk, Nathorn and Khaing, Win and Veettil, Sajesh K and McFarland, Mary M and Casucci, Tallie and Xu, Yizhe and Hu-Lieskovan, Siwen and Litchman, Michelle and Playdon, Mary and Hardikar, Sheetal},
title = {Metabolic Syndrome and Obesity‐related cancer Risk and Survival: An Umbrella Review of Systematic Reviews With Meta‐analysis of Observational Studies},
journal = {Obesity Reviews},
year = {2026},
doi = {10.1111/obr.70073}
}
EUVIMED